You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Older adults 60 years of age and above

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Placebo
  • Daphne, Alabama
  • +56 more
Jan 20, 2023

Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Charlottesville, Virginia
    University of Virginia
Jul 27, 2022

Influenza Immunization Trial in Australia (H3 mRNA / LNP Vaccine, Quadrivalent recombinant influenza Vaccine (RIV4))

Recruiting
  • Influenza Immunization
  • H3 mRNA / LNP Vaccine
  • Quadrivalent recombinant influenza Vaccine (RIV4)
  • Herston, Queensland, Australia
  • +3 more
May 1, 2023

Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and

Recruiting
  • Community Acquired Pneumonia (CAP)
  • Urine sample collection
  • Saliva collection
  • Getafe, Madrid, Spain
  • +5 more
Dec 7, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • PCV20
  • (no location specified)
May 18, 2023

Healthy Trial in Hollywood, Atlanta, Omaha (IVX-121, IVX-241, Placebo)

Recruiting
  • Healthy
  • IVX-121
  • +3 more
  • Hollywood, Florida
  • +2 more
Dec 22, 2022

Aging Trial (Adjusted Cognitive-biased modification task, Cognitive-biased modification task)

Not yet recruiting
  • Aging
  • Adjusted Cognitive-biased modification task
  • Cognitive-biased modification task
  • (no location specified)
Jan 26, 2023

Oral Processing and Appetite in Older Adults

Not yet recruiting
  • Older Adults
  • +3 more
    • Reading, United Kingdom
      University of Reading
    Jan 2, 2023

    Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)

    Completed
    Has Results
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU-QIV
    • Auckland, New Zealand
    • +13 more
    Sep 20, 2022

    SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)

    Not yet recruiting
    • SARS CoV 2 Infection
    • Influenza, Human
    • BIMERVAX
    • SIIV
    • Santiago De Compostela, A Coruña, Spain
    • +7 more
    Aug 8, 2023

    Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

    Not yet recruiting
    • Norovirus Acute Gastroenteritis
    • mRNA-1403
    • +2 more
    • Long Beach, California
    • +14 more
    Aug 7, 2023

    Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)

    Recruiting
    • Vaccine-Preventable Diseases
    • Herpes Zoster
    • CVI-VZV-001
    • Shingrix
    • Seoul, Eunpyeong-gu, Korea, Republic of
    • +1 more
    Nov 20, 2023

    Healthy Trial in United States (IVX-A12, Placebo)

    Recruiting
    • Healthy
    • IVX-A12
    • Placebo
    • Tempe, Arizona
    • +9 more
    Jun 5, 2023

    COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

    Active, not recruiting
    • COVID-19
    • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
    • ZF2001
    • Wuhan, Hubei, China
      Hubei Provincial Center for Disease Control and Prevention
    Jan 12, 2023

    Healthy Trial in Buenos Aires (RSVpreF+qIRV, qIRV, RSVpreF)

    Recruiting
    • Healthy
    • RSVpreF+qIRV
    • +3 more
    • Buenos Aires, Argentina
      Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
    Mar 27, 2023

    COVID-19 Trial in Chongqing, Jinan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, Placebo)

    Active, not recruiting
    • COVID-19
    • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
    • Placebo
    • Chongqing, Chongqing, China
    • +1 more
    Jan 11, 2023

    Exercise, Physical Activity Trial in Boston (Companion)

    Active, not recruiting
    • Exercise
    • Physical Activity
    • Companion
    • Boston, Massachusetts
      Northeastern Univeristy
    Nov 14, 2022

    Respiratory Syncytial Virus Infection Trial in Puerto Rico, United States (RSV mRNA LNP CL-0059 Low dose, RSV mRNA LNP CL-0137

    Recruiting
    • Respiratory Syncytial Virus Infection
    • RSV mRNA LNP CL-0059 Low dose
    • +6 more
    • Hollywood, Florida
    • +4 more
    Jan 17, 2023

    Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

    Not yet recruiting
    • Influenza, Human
    • FLU Q-PAN H5N8 Formulation 1
    • +3 more
    • (no location specified)
    Jul 27, 2023

    Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)

    Completed
    • Pneumococcal Disease
    • 20vPnC
    • +3 more
    • Itoshima, Fukuoka, Japan
    • +27 more
    Dec 5, 2022

    COVID-19 Trial in Nanjing, Hangzhou (20 µg dose of SYS6006, 30 µg dose of SYS6006, Placebo)

    Enrolling by invitation
    • SARS-CoV-2
    • 20 μg dose of SYS6006 ;30 μg dose of SYS6006
    • Placebo
    • Nanjing, Jiangsu, China
    • +1 more
    Dec 20, 2022

    Influenza (Healthy Volunteers) Trial in Worldwide (Standard-Dose influenza virus surface antigens (haemagglutinin and

    Completed
    Has Results
    • Influenza (Healthy Volunteers)
    • Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)
    • High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northern Hemisphere formulation
    • Gent, Belgium
    • +16 more
    Mar 24, 2022

    Corona Virus Infection, Vaccine, COVID-19 Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated

    Active, not recruiting
    • Corona Virus Infection
    • +2 more
    • CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
    • Elektrostal, Moscow Oblast, Russian Federation
    • +6 more
    Mar 9, 2023

    Men, Age Problem, Therapeutic Alliance Trial in Moscow (Non-intervention)

    Not yet recruiting
    • Men
    • +2 more
    • Non-intervention
    • Moscow, Russian Federation
      Eurasian Association of Therapists
    Feb 1, 2022

    COVID-19 Trial in Kunming (ZR-202-CoV, Placebo)

    Recruiting
    • COVID-19
    • ZR-202-CoV
    • Placebo
    • Kunming, Yunan, China
      Clinical Trial Institution for Anning First Hospital
    Apr 5, 2022